comparemela.com

Latest Breaking News On - Sylvia wimmer - Page 8 : comparemela.com

Heidelberg Pharma s Partner Telix Reports Positive Data on the Pivotal ZIRCON Study

EQS-News: Heidelberg Pharma AG / Key word(s): AllianceHeidelberg Pharma’s Partner Telix Reports Positive Data on the Pivotal ZIRCON Study 07.11.2022 / 11:49 CET/CESTThe issuer is solely responsible for the content of this announcement.PRESS RELEASEHeidelberg Pharma’s Partner Telix Reports Positive Data on the Pivota.

United statesSylvia wimmerHeidelberg pharmaMc servicesTelix pharmaceuticalsCorporate communicationsFrankfurt stock exchangeHeidelberg pharma research gmbDistribution servicesPartner telix reports positive dataTelix pharmaceuticals limitedAbout heidelberg pharmaHeidelberg pharma researchCorporate newsRegulatory announcements

EQS-Adhoc: Heidelberg Pharma AG Announces Adjustment of Guidance

EQS-Ad-hoc: Heidelberg Pharma AG / Key word(s): Change in Forecast Heidelberg Pharma AG Announces Adjustment of Guidance 04-Oct-2022 / 17:50 .

Heidelberg pharmasSylvia wimmerHeidelberg pharmaMc servicesHuadong medicine co ltdHeidelberg pharma groupFrankfurt stock exchangeHeidelberg pharma research gmbDistribution servicesInterim management statementHeidelberg pharma researchRegulatory announcementsCorporate news

Investegate |Heidelberg Pharma AG Announcements | Heidelberg Pharma AG: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate

Investegate announcements from Heidelberg Pharma AG, Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate

Sylvia wimmerHeidelberg pharmaMc servicesCorporate communicationsFrankfurt stock exchangeHeidelberg pharma research gmbDistribution servicesPharma announces conclusionLicense agreementPartner takeda to developAntibody targeted amanitinHeidelberg pharma research gmbhAntibody targeted amanitin conjugateAntibody drug conjugatesHeidelberg pharma researchRegulatory announcements

DGAP-Adhoc: Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate

DGAP-Ad-hoc: Heidelberg Pharma AG / Key word(s): Alliance Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To D.

Sylvia wimmerHeidelberg pharmaMc servicesCorporate communicationsFrankfurt stock exchangeHeidelberg pharma research gmbDistribution servicesPharma announces conclusionLicense agreementPartner takeda to developAntibody targeted amanitin conjugateAntibody targeted amanitinHeidelberg pharma research gmbhAntibody drug conjugatesHeidelberg pharma researchRegulatory announcements

DGAP-News: Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital Measure

DGAP-News: Heidelberg Pharma AG / Key word(s): Corporate Action Heidelberg Pharma AG Raises Approximately EUR 80 Million From Capital.

Baden wübergSylvia wimmerHeidelberg pharmaMc servicesFrankfurt stock exchangeUnited statesBaader bankRegister at mannheim local courtHuadong medicine co ltdGmbh coCorporate communicationsHeidelberg pharma research gmbFrom capitalHuadong investmentCommercial registerMannheim local court

vimarsana © 2020. All Rights Reserved.